Making sense of AIDSVAX.
Preliminary data from the manufacturer of AIDSVAX presented in a February press conference indicate overall disappointing results from their large vaccine trial, but some intriguing results among the small numbers of non-white volunteers.
Albrecht
H
H
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D001741:Black or African American; D004311:Double-Blind Method; D005260:Female; D015658:HIV Infections / Q000208:ethnology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010919:Placebos; D012309:Risk-Taking; D012725:Sexual Behavior; D044465:White People
D016915:AIDS Vaccines; C112734:AIDSVAX; D010919:Placebos